Associated Papers
[Use of IL-1 inhibitors in the treatment of familial Mediterranean fever in pediatric rheumatology].
Hillekamp C et al.
Zeitschrift Fur Rheumatologie, 2025
Implementation of long-read sequencing for routine molecular diagnosis of familial mediterranean fever.
Vanhoye X et al.
Practical Laboratory Medicine, 2024
Epigenetic, transcriptional, and functional characterization of myeloid cells in familial Mediterranean fever.
Röring RJ et al.
Iscience, 2024
Peripheral T Cell Populations are Differentially Affected in Familial Mediterranean Fever, Chronic Granulomatous Disease, and Gout.
Al B et al.
Journal of Clinical Immunology, 2023
Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center.
Peet CJ et al.
Journal of the American Heart Association, 2022
A comprehensive molecular analysis and genotype-phenotype correlation in patients with familial mediterranean fever.
Balta B et al.
Molecular Biology Reports, 2020
Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing.
Alexiadis M et al.
Molecular Cancer Research : Mcr, 2019
Complex formation dynamics of native and mutated pyrin's B30.2 domain with caspase-1.
Arakelov G et al.
Proteins, 2018
Comprehensive analysis of mutations in the MEFV gene reveal that the location and not the substitution type determines symptom severity in FMF.
Moradian MM et al.
Molecular Genetics & Genomic Medicine, 2017
Clinical Review: Familial Mediterranean Fever-An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment.
Petrushkin H et al.
Ocular Immunology and Inflammation, 2016
An updated view on the structure and function of PYRIN domains.
Chu LH et al.
Apoptosis : an International Journal on Programmed Cell Death, 2015
Identification of multifaceted binding modes for pyrin and ASC pyrin domains gives insights into pyrin inflammasome assembly.
Vajjhala PR et al.
The Journal of Biological Chemistry, 2014
Familial Mediterranean fever: An updated review.
Sarı İ et al.
European Journal of Rheumatology, 2014
Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype.
Omenetti A et al.
Annals of the Rheumatic Diseases, 2014
Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
Grattagliano I et al.
Clinical Pharmacology and Therapeutics, 2014
Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations.
Moradian MM et al.
Journal of Human Genetics, 2010
CATERPILLERs, pyrin and hereditary immunological disorders.
Ting JP et al.
Nature Reviews. Immunology, 2006
Role of charged and hydrophobic residues in the oligomerization of the PYRIN domain of ASC.
Moriya M et al.
Biochemistry, 2005
In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics.
Tchernitchko D et al.
Clinical Chemistry, 2004
The spectrum of Familial Mediterranean Fever (FMF) mutations.
Touitou I
European Journal of Human Genetics : Ejhg, 2001
Association between familial mediterranean fever and retroperitoneal fibrosis: retroperitoneal fibrosis regression after colchicine therapy.
De Socio G et al.
International Journal of Immunopathology and Pharmacology, 0